Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice.
作者信息
Baldwin Grant T, Seth Puja, Noonan Rita K
机构信息
Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
JAMA. 2021 Mar 23;325(12):1151-1152. doi: 10.1001/jama.2021.1169.
Abstract
摘要
相似文献
1
Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice.
JAMA. 2021 Mar 23;325(12):1151-1152. doi: 10.1001/jama.2021.1169.
2
Increases in Online Posts About Synthetic Opioids Preceding Increases in Synthetic Opioid Death Rates: a Retrospective Observational Study.
J Gen Intern Med. 2019 Dec;34(12):2702-2704. doi: 10.1007/s11606-019-05255-5.
3
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis.
Int J Drug Policy. 2019 Sep;71:183-188. doi: 10.1016/j.drugpo.2019.01.010. Epub 2019 Feb 2.
4
Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid-Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas - United States, 2015-2017.
MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):967-973. doi: 10.15585/mmwr.mm6843a3.
5
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
6
Addressing the Fentanyl Threat to Public Health.
N Engl J Med. 2017 Feb 16;376(7):605-607. doi: 10.1056/NEJMp1615145.
7
Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
8
Will Emergency Holds Reduce Opioid Overdose Deaths?
N Engl J Med. 2019 Nov 7;381(19):1795-1797. doi: 10.1056/NEJMp1907692. Epub 2019 Oct 16.
9
Underlying Factors in Drug Overdose Deaths.
JAMA. 2017 Dec 19;318(23):2295-2296. doi: 10.1001/jama.2017.15971.
10
The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis.
Public Health Rep. 2020 Jan;135(1):6-10. doi: 10.1177/0033354919887741. Epub 2019 Nov 18.
引用本文的文献
1
Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting.
JAMA Netw Open. 2025 Aug 1;8(8):e2527016. doi: 10.1001/jamanetworkopen.2025.27016.
2
In vitro and in vivo pharmacological characterization of fentanyl analogs.
Neuropharmacology. 2025 Nov 15;279:110603. doi: 10.1016/j.neuropharm.2025.110603. Epub 2025 Jul 26.
3
Understanding Opioid Use from Retrospective Accounts of Young Adults in Recovery: Motives, Experiences, and Implications for Prevention.
J Prev (2022). 2025 Jun 27. doi: 10.1007/s10935-025-00861-y.
4
Rise in deaths from drug overdose and firearm injury during coronavirus disease 2019 pandemic and its impact on organ transplantation.
World J Transplant. 2025 Jun 18;15(2):101986. doi: 10.5500/wjt.v15.i2.101986.
5
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption.
Neuropharmacology. 2025 Jun 12;278:110562. doi: 10.1016/j.neuropharm.2025.110562.
6
Heroin, Fentanyl, Intentional Fentanyl Use and HIV Transmission in a Community-Recruited Sample of Persons Who Inject Drugs, New York City: 2021-2023.
AIDS Behav. 2025 Apr 24. doi: 10.1007/s10461-025-04732-9.
7
Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl.
JAMA Netw Open. 2025 Jan 2;8(1):e2456253. doi: 10.1001/jamanetworkopen.2024.56253.
8
Microvascular Dysfunction, Mitochondrial Reprogramming, and Inflammasome Activation as Critical Regulators of Ischemic Stroke Severity Induced by Chronic Exposure to Prescription Opioids.
J Neurosci. 2025 Feb 19;45(8):e0614242024. doi: 10.1523/JNEUROSCI.0614-24.2024.
9
Medications for opioid use disorders among incarcerated persons and those in the community supervision setting: exploration of implementation issues with key stakeholders.
Addict Sci Clin Pract. 2024 Dec 18;19(1):95. doi: 10.1186/s13722-024-00528-9.
10
Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.
J Clin Pharmacol. 2025 Feb;65(2):206-216. doi: 10.1002/jcph.6132. Epub 2024 Sep 30.
本文引用的文献
1
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
2
Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected - 28 States and the District of Columbia, July 2016-December 2018.
MMWR Morb Mortal Wkly Rep. 2020 Mar 13;69(10):271-273. doi: 10.15585/mmwr.mm6910a4.
3
The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Addiction. 2020 May;115(5):946-958. doi: 10.1111/add.14878. Epub 2020 Jan 7.
4
Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017.
MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):388-395. doi: 10.15585/mmwr.mm6817a3.
5
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
Zotero 插件